---
figid: PMC7921306__fmed-08-622225-g0001
figlink: pmc/articles/PMC7921306/figure/F1/
number: F1
caption: Genomic and non-genomic mechanisms of glucocorticoids. Glucocorticoid genomic
  pathway is mediated through the cytoplasmic glucocorticoid receptor (cGR) leading
  to the mechanisms of gene transactivation and transrepression. The non-genomic pathway
  is mediated through the membrane glucocorticoid receptor (mGR), inhibition of the
  phospholipase A2, and changes in cell membranes. The arrow in the left depicts the
  dose of prednisone required to activate these pathways. The upper and lower gray
  zones represent the doses were genomic (lower gray zone) and non-genomic (upper
  gray zone) are fully saturated without added benefit and with higher incidence of
  adverse effects. mGR, membrane glucocorticoid receptor; PLA2, phospholipase A2;
  cGR, cytoplasmic glucocorticoid receptor; GRE, glucocorticoid response element;
  Hsp70·HOP·Hsp90, multiprotein complex including chaperones such as heat shock proteins
  and the glucocorticoid receptor; Hsp90·FKBP52·p23, multiprotein complex including
  chaperones, co-chaperones, and the glucocorticoid receptor.
pmcid: PMC7921306
papertitle: 'The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old
  Drug.'
reftext: Juan M. Mejía-Vilet, et al. Front Med (Lausanne). 2021;8:622225.
pmc_ranked_result_index: '20355'
pathway_score: 0.8968601
filename: fmed-08-622225-g0001.jpg
figtitle: Genomic and non-genomic mechanisms of glucocorticoids
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7921306__fmed-08-622225-g0001.html
  '@type': Dataset
  description: Genomic and non-genomic mechanisms of glucocorticoids. Glucocorticoid
    genomic pathway is mediated through the cytoplasmic glucocorticoid receptor (cGR)
    leading to the mechanisms of gene transactivation and transrepression. The non-genomic
    pathway is mediated through the membrane glucocorticoid receptor (mGR), inhibition
    of the phospholipase A2, and changes in cell membranes. The arrow in the left
    depicts the dose of prednisone required to activate these pathways. The upper
    and lower gray zones represent the doses were genomic (lower gray zone) and non-genomic
    (upper gray zone) are fully saturated without added benefit and with higher incidence
    of adverse effects. mGR, membrane glucocorticoid receptor; PLA2, phospholipase
    A2; cGR, cytoplasmic glucocorticoid receptor; GRE, glucocorticoid response element;
    Hsp70·HOP·Hsp90, multiprotein complex including chaperones such as heat shock
    proteins and the glucocorticoid receptor; Hsp90·FKBP52·p23, multiprotein complex
    including chaperones, co-chaperones, and the glucocorticoid receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GRHL1
  - PLA2G1B
  - PLA2G2A
  - PLA2G5
  - PLA2G10
  - PLA2G2D
  - PLA2G2E
  - PLA2G3
  - PLA2G2F
  - PLA2G12A
  - PLA2G4D
  - PLA2G2C
  - PLA2G4A
  - PLA2G7
  - PLA2G6
  - PLA2G4C
  - PLA2G12B
  - HSP90AA1
  - FKBP4
  - TNF
  - IL6
  - IL10
  - PER1
  - prednisone
genes:
- word: mGR
  symbol: MGR
  source: hgnc_alias_symbol
  hgnc_symbol: GRHL1
  entrez: '29841'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: Hsp90
  symbol: Hsp90
  source: hgnc_alias_symbol
  hgnc_symbol: HSP90AA1
  entrez: '3320'
- word: FKBP52
  symbol: FKBP52
  source: hgnc_alias_symbol
  hgnc_symbol: FKBP4
  entrez: '2288'
- word: Hsp90
  symbol: Hsp90
  source: hgnc_alias_symbol
  hgnc_symbol: HSP90AA1
  entrez: '3320'
- word: TNF¤)
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: (IL-6,TNF¤)
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: (IL-6,
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: (IL-10,
  symbol: IL10
  source: hgnc_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: per
  symbol: PER
  source: hgnc_prev_symbol
  hgnc_symbol: PER1
  entrez: '5187'
chemicals:
- word: prednisone
  source: MESH
  identifier: D011241
diseases: []
figid_alias: PMC7921306__F1
redirect_from: /figures/PMC7921306__F1
figtype: Figure
---
